Page last updated: 2024-10-26

dipyridamole and Essential Polyarteritis

dipyridamole has been researched along with Essential Polyarteritis in 2 studies

Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Corbeel, L1
Gewillig, M1
Baeten, E1
Casteels-Van Daele, M1
Eggermont, E1
Friedman, A1
Kincaid-Smith, P1

Other Studies

2 other studies available for dipyridamole and Essential Polyarteritis

ArticleYear
Carotid and coronary artery involvement in infantile periarteritis nodosa possibly induced by Coxsackie B4 infection. Favourable course under corticosteroid treatment.
    European journal of pediatrics, 1987, Volume: 146, Issue:4

    Topics: Aspirin; Carotid Artery Diseases; Coronary Disease; Coxsackievirus Infections; Dexamethasone; Dipyri

1987
Arteritis with impaired renal function.
    Perspectives in nephrology and hypertension, 1973, Volume: 1 Pt 2, Issue:0

    Topics: Adult; Aged; Anticoagulants; Azathioprine; Biopsy; Cyclophosphamide; Dipyridamole; Drug Therapy, Com

1973